T Glimet P 1mg/500mg/15mg Tablet ER
Marketer
Torance Healthcare Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview T Glimet P 1mg/500mg/15mg Tablet ER
Glimepiride/Metformin/Pioglitazone extended-release tablets (1mg/500mg/15mg) manage blood glucose levels in adults with type 2 diabetes. Used alongside diet and exercise, this combined medication enhances insulin effectiveness, reducing blood sugar. Follow your doctor's prescribed dosage and frequency; take with food to prevent stomach discomfort. If a dose is missed, take it immediately unless the next dose is imminent; never double the dose. Overdosage can cause dangerously low blood sugar (hypoglycemia). Hypoglycemia risk increases when combined with other diabetes medications, alcohol, or skipped meals; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Patients with kidney, liver, or heart conditions, or those who are pregnant or breastfeeding, must consult their physician before use. Kidney function tests will be performed before treatment. Limit alcohol consumption to minimize side effect risk.
Primary Ingredients of T Glimet P 1mg/500mg/15mg Tablet ER
The provided text is "undefined," therefore no rephrasing is possible.
Uses of T Glimet P 1mg/500mg/15mg Tablet ER
Managing type 2 diabetes
Major Benefits of T Glimet P 1mg/500mg/15mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Consume T Glimet P 1mg/500mg/15mg Extended-Release Tablets with food.
Common Side effects of T Glimet P 1mg/500mg/15mg Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use T Glimet P 1mg/500mg/15mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing. Consume T Glimet P 1mg/500mg/15mg Extended-Release tablets with food.
How T Glimet P 1mg/500mg/15mg Tablet ER works:
T Glimet P 1mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-drug approach improves blood sugar management when single or dual medications prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking T Glimet P 1mg/500mg/15mg Extended-Release tablets is hazardous.
PregnancyCONSULT YOUR DOCTOR
Extended-release T Glimet P tablets (1mg/500mg/15mg) might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release T Glimet P tablets (1mg/500mg/15mg) are likely unsafe for breastfeeding mothers. Available evidence from humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Individuals with kidney impairment should use T Glimet P 1mg/500mg/15mg Tablet ER cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with hepatic impairment should use T Glimet P 1mg/500mg/15mg Tablet ER cautiously, potentially requiring dosage modification. Physician consultation is advised. T Glimet P 1mg/500mg/15mg Tablet ER is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take T Glimet P 1mg/500mg/15mg Tablet ER :
Should you forget a dose of T Glimet P 1mg/500mg/15mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About T Glimet P 1mg/500mg/15mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently